MSH|^~\&|PathSys|PathGroup^44D2062928^CLIA|eMaRC|TNCR|20240819175535||ORU^R01^ORU_R01|PGR_ELRTNCR_20240819175535|P|2.5.1|||||||||VOL_V_51_ORU_R01^NAACCR_CP
PID|1||651984659^^^Davis&1568635704&NPI^MR^Davis&1568635704&NPI~999999999^^^USSSA^SS^~1568635704^^^PathGroup&44D2062928&CLIA^PI^PathGroup&44D2062928&CLIA||TEST-CCR^MESSAGE1^^^^^L||19821010|F|||1234 TESTING DR^^FRANKLIN^TN^37064^USA||^PRN^PH^^1^615^5551234
PV1|1|N|||||||||||||||||
ORC|RE||||||||||||||||||||Test Client^^^^^NPI^^^^1568635704|658 Grassmere Park^Suite 101^Brentwood^TN^37027^USA|^WPN^PH^^1^615^4262932|1004 N. Highland Ave.^^Murfreesboro^TN^37130^USA
OBR|1||24-11-000312^PathSys^44D2062928^CLIA|35265-8^PATH REPORT ADDENDUM^LN|||20240808000000|||||||20240808000000|TISS&Tissue&HL70487|1568635704^Davis^Amanda^C^^^MD^^CMS^D^^^NPI||||||20240808000000|||F||||||C73^Malignant neoplasm of thyroid gland^I10~C77.0^Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck^I10|1093955338&Chandra&Pranil&K.&&&&&NPI
OBX|1|TX|22637-3^Path report.final diagnosis^LN|1|1.  Thyroid, total thyroidectomy:\X0D\\X0A\              Papillary thyroid carcinoma, classic type.\X0D\\X0A\              Tumor measures 1.2 cm in greatest dimension and is limited to the thyroid.\X0D\\X0A\              Pathologic stage:  pT1b, pN1a, pMX.\X0D\\X0A\              Two of six lymph nodes positive for metastatic papillary thyroid carcinoma\X0D\\X0A\                      (2/6).\X0D\\X0A\              All surgical resection margins free of tumor.\X0D\\X0A\  \X0D\\X0A\  2.  Central compartment tissue, excision:\X0D\\X0A\              Two lymph nodes identified, all negative for metastatic carcinoma (0/2).\X0D\\X0A\  \X0D\\X0A\  CANCER CHECKLIST: THYROID GLAND\X0D\\X0A\  Thyroid gland\X0D\\X0A\  SPECIMEN\X0D\\X0A\    Procedure:  Total thyroidectomy\X0D\\X0A\  TUMOR\X0D\\X0A\    Tumor Focality:  Unifocal\X0D\\X0A\    Tumor Site:  Left lobe\X0D\\X0A\    Tumor Size:\X0D\\X0A\    Greatest dimension in Centimeters (cm):  1.2 cm\X0D\\X0A\    Additional Dimension in Centimeters (cm):  1.0 cm\X0D\\X0A\    Additional Dimension in Centimeters (cm):  0.8 cm\X0D\\X0A\    Papillary thyroid carcinomas\X0D\\X0A\    Papillary carcinoma, classic subtype\X0D\\X0A\    Mitotic Rate:  Less than 3 mitoses per 2mm2\X0D\\X0A\    Tumor Necrosis:  Not identified\X0D\\X0A\    Angioinvasion (vascular invasion):  Not identified\X0D\\X0A\    Lymphatic Invasion:  Not identified\X0D\\X0A\    Perineural Invasion:  Not identified\X0D\\X0A\    Extrathyroidal Extension:  Not identified\X0D\\X0A\    Margin Status:  All margins negative for carcinoma\X0D\\X0A\  REGIONAL LYMPH NODES\X0D\\X0A\    Number of Lymph Nodes with Tumor:  Exact number (specify)\X0D\\X0A\    Exact number (specify):  2\X0D\\X0A\    Nodal Level(s) Involved:  Level VI - pretracheal, paratracheal and prelaryngeal /\X0D\\X0A\  Delphian, perithyroidal (central compartment dissection)\X0D\\X0A\    Size of Largest Metastatic Deposit:\X0D\\X0A\    Exact size:  0.2\X0D\\X0A\    Extranodal Extension (ENE):  Not identified\X0D\\X0A\    Number of Lymph Nodes Examined:  Exact number (specify)\X0D\\X0A\    Exact number (specify):  8\X0D\\X0A\    Nodal Level(s) Examined:  Level VI - pretracheal, paratracheal and prelaryngeal /\X0D\\X0A\  Delphian, perithyroidal (central compartment dissection)\X0D\\X0A\  DISTANT METASTASIS\X0D\\X0A\    Distant Site(s) Involved, if applicable:  Not applicable\X0D\\X0A\  pTNM CLASSIFICATION (AJCC 8th Edition)\X0D\\X0A\    Modified Classification (required only if applicable):  Not applicable\X0D\\X0A\    pT Category:  pT1b: Tumor greater than 1 cm but less than or equal to 2 cm in\X0D\\X0A\  greatest dimension, limited to the thyroid\X0D\\X0A\    pN Categorp:  pN1a: Metastasis to level VI or VII (pretracheal, paratracheal, or\X0D\\X0A\  prelaryngeal / Delphian, or upper mediastinal) lymph nodes. This can be unilateral or\X0D\\X0A\  bilateral disease.\X0D\\X0A\  ADDITIONAL FINDINGS\X0D\\X0A\    Additional Findings:  Thyroiditis (specify type)\X0D\\X0A\    Thyroiditis (specify type):  Hashimoto's thyroiditis||||||F|||202401031239|44D2062928^PathGroup^CLIA||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|2|TX|22633-2^Path report.site of origin^LN|1|1. Thyroid\X0D\\X0A\  2. Central compartment tissue||||||F|||202401031239|44D2062928^PathGroup^CLIA||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|3|TX|22634-0^Path report.gross description^LN|1|Specimen #1, received in formalin designated "xxxx" and\X0D\\X0A\  "thyroid", is a total of thyroid that weighs 12 grams and is received unoriented.  The\X0D\\X0A\  presumed right lobe measures 3.3 superior inferior, 1.8 medial lateral and 1.5\X0D\\X0A\  anterior posterior; the isthmus measures 1.9 superior inferior, 1.3 medial lateral and\X0D\\X0A\  0.6 anterior posterior.  The left lobe measures 3.7 superior inferior, 1.8 medial lateral\X0D\\X0A\  and 1.5 anterior posterior with an attached yellow lobulated adipose tissue at the\X0D\\X0A\  inferior pole that measures 1.7 x 1.6 x 0.7 cm.  The entire surface of the thyroid\X0D\\X0A\  varies from dark-pink to pale-yellow at the isthmus area.  The entire anterior surface\X0D\\X0A\  is inked blue, the posterior black and the anterior surface of the isthmus overlaid with\X0D\\X0A\  orange ink.  The attached fatty tissue through the inferior pole of the lobe is also\X0D\\X0A\  inked blue on its anterior surface and black on its posterior surface.  Prior to\X0D\\X0A\  sectioning of the right lobe, the cut-surfaces demonstrate scattered colloid filled\X0D\\X0A\  nodules that measure up to 0.7 cm in maximum dimensions.  The isthmus is\X0D\\X0A\  sectioned from right to left and the cut-surfaces appear dark-pink and homogenous.\X0D\\X0A\   Sections of the left lobe demonstrate a white dense predominant nodule extending\X0D\\X0A\  from the lower inferior to most of the mid portion of the thyroid lobe and this nodule\X0D\\X0A\  measures 1.2 x 1.0 x 0.8 cm.  At the attached fatty area of the inferior pole of the left\X0D\\X0A\  lobe dark-pink scattered homogenous thyroid parenchyma is noted.  Representative\X0D\\X0A\  sections are submitted as follows:\X0D\\X0A\  \X0D\\X0A\       1A:            Superior pole.\X0D\\X0A\       1B-1C:      Intervening representative mid sections.\X0D\\X0A\       1D:            Inferior pole.\X0D\\X0A\       1E-1F:      Right to left representative sections of the isthmus.\X0D\\X0A\       1G:            From the left lobe.\X0D\\X0A\       1H-1I:        Sections demonstrating the predominant white and dense nodule.\X0D\\X0A\       1J:             Additional sections from the inferior of pole of the left lobe.\X0D\\X0A\       1K:            Most inferior pole of the left lobe.\X0D\\X0A\       1L:            Additional sections from fatty tissue attached to the inferior pole of the\X0D\\X0A\                              left lobe.\X0D\\X0A\  \X0D\\X0A\  Specimen #2, received in formalin designated "xxxx" and "central\X0D\\X0A\  compartment tissue", is an irregular and rubbery nodular unoriented tissue\X0D\\X0A\  measuring 1.8 x 1.1 x 1.0 cm.  It appears dark-pink to pale-yellow cauterized and\X0D\\X0A\  nodular.  The entire surgical margin of the specimen is inked green.  The entire\X0D\\X0A\  specimen is sectioned and the cut-surfaces demonstrate primarily yellow-lobulated\X0D\\X0A\  cut-surfaces with focal pink and tan areas possibly thyroid parenchyma.  The\X0D\\X0A\  specimen is totally submitted in cassettes 2A-2B.||||||F|||202401031239|44D2062928^PathGroup^CLIA||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|4|TX|22635-7^Path report.microscopic examination^LN|1|Microscopic examination is performed on multiple sections, 14 slides in total.||||||F|||202401031239|44D2062928^PathGroup^CLIA||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|5|TX|22636-5^Path report.relevant Hx^LN|1|History - History of left thyroid papillary thyroid carcinoma diagnosed on previous FNA (23-28\X0D\\X0A\  -250). (BS/cn)||||||F|||202401031239|44D2062928^PathGroup^CLIA||||||||PathGroup^^^^^FI^^^^44D2062928
SPM|1|^1000479970||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|2|^1000479971||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|3|^1000479972||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|4|^1000479973||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|5|^1000479974||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|6|^1000479975||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|7|^1000479976||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|8|^1000479977||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|9|^1000479978||TISS^Tissue^HL70487|K^Block^HL70541|||^^^88305^Soft Tissue, other than tumor,mass,lipoma,debride^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|10|^1000479979||TISS^Tissue^HL70487|K^Block^HL70541|||^^^88305^Soft Tissue, other than tumor,mass,lipoma,debride^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
OBR|2||24-11-000312^PathSys^44D2062928^CLIA|60569-1^REPORT ADDENDUM.SYNOPTIC^LN|||20240808000000|||||||20240808000000|TISS&Tissue&HL70487|1568635704^Davis^Amanda^C^^^MD^^CMS^D^^^NPI||||||20240808000000|||F|||||||1093955338&Chandra&Pranil&K.&&&&&NPI
OBX|1|ST|60573-3^Report Template Source^LN||CAP eCP||||||F|||202408081235||||||||
OBX|2|CWE|60572-5^Report Template ID^LN||175.100004300^THYROID GLAND^CAPECP||||||F|||202408081235||||||||
OBX|3|ST|60574-1^Report Template Version ID^LN||4.005.001.REL||||||F|||202408081235||||||||
OBX|4|CWE|22371.100004300^^CAPECP||22372.100004300^Thyroid gland^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|5|CWE|51121.100004300^Procedure^CAPECP||8609.100004300^Total thyroidectomy^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|6|CWE|8722.100004300^Tumor Focality^CAPECP||8723.100004300^Unifocal^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|7|CWE|48385.100004300^Tumor Site^CAPECP||8719.100004300^Left lobe^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|8|CWE|20791.100004300^Tumor Size^CAPECP|20793|20793.100004300^Greatest dimension in Centimeters (cm)^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|9|NM|20791.100004300^Tumor Size^CAPECP|20793|1.2|cm^Centimeter^UCUM|||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|10|NM|20795.100004300^Additional Dimension in Centimeters (cm)^CAPECP||1.0|cm^Centimeter^UCUM|||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|11|NM|20794.100004300^Additional Dimension in Centimeters (cm)^CAPECP||0.8|cm^Centimeter^UCUM|||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|12|CWE|847097.100004300^^CAPECP||847100.100004300^Papillary thyroid carcinomas^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|13|CWE|847127.100004300^^CAPECP||8965.100004300^Papillary carcinoma, classic subtype^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|14|CWE|846590.100004300^Mitotic Rate^CAPECP||846594.100004300^Less than 3 mitoses per 2mm2^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|15|CWE|354220.100004300^Tumor Necrosis^CAPECP||354222.100004300^Not identified^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|16|CWE|846613.100004300^Angioinvasion (vascular invasion)^CAPECP||31468.100004300^Not identified^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|17|CWE|31474.100004300^Lymphatic Invasion^CAPECP||31475.100004300^Not identified^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|18|CWE|24291.100004300^Perineural Invasion^CAPECP||24295.100004300^Not identified^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|19|CWE|847058.100004300^Extrathyroidal Extension^CAPECP||9507.100004300^Not identified^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|20|CWE|9431.100004300^Margin Status^CAPECP||9477.100004300^All margins negative for carcinoma^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|21|CWE|38976.100004300^Number of Lymph Nodes with Tumor^CAPECP|11812|11812.100004300^Exact number (specify)^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|22|ST|38976.100004300^Number of Lymph Nodes with Tumor^CAPECP|11812|2||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|23|CWE|43806.100004300^Nodal Level(s) Involved^CAPECP||41014.100004300^Level VI - pretracheal, paratracheal and prelaryngeal / Delphian, perithyroidal (central compartment dissection)^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|24|CWE|46095.100004300^Size of Largest Metastatic Deposit^CAPECP|54880|54880.100004300^Exact size^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|25|ST|46095.100004300^Size of Largest Metastatic Deposit^CAPECP|54880|0.2||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|26|CWE|24301.100004300^Extranodal Extension (ENE)^CAPECP||24302.100004300^Not identified^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|27|CWE|33889.100004300^Number of Lymph Nodes Examined^CAPECP|11809|11809.100004300^Exact number (specify)^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|28|ST|33889.100004300^Number of Lymph Nodes Examined^CAPECP|11809|8||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|29|CWE|43847.100004300^Nodal Level(s) Examined^CAPECP||37685.100004300^Level VI - pretracheal, paratracheal and prelaryngeal / Delphian, perithyroidal (central compartment dissection)^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|30|CWE|354167.100004300^Distant Site(s) Involved, if applicable^CAPECP||354172.100004300^Not applicable^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|31|CWE|847067.100004300^Modified Classification (required only if applicable)^CAPECP||847280.100004300^Not applicable^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|32|CWE|327750.100004300^pT Category^CAPECP||24299.100004300^pT1b: Tumor greater than 1 cm but less than or equal to 2 cm in greatest dimension, limited to the thyroid^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|33|CWE|327755.100004300^pN Category#^CAPECP||38046.100004300^pN1a: Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal / Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease.^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|34|CWE|847075.100004300^Additional Findings^CAPECP|9554|9554.100004300^Thyroiditis (specify type)^CAPECP||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
OBX|35|ST|847075.100004300^Additional Findings^CAPECP|9554|Hashimoto's thyroiditis||||||F|||202408081235|||||||||PathGroup^^^^^FI^^^^44D2062928
SPM|1|^1000479970||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|2|^1000479971||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|3|^1000479972||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|4|^1000479973||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|5|^1000479974||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|6|^1000479975||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|7|^1000479976||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|8|^1000479977||OTH^Source, other^HL70487|K^Block^HL70541|||^^^88307^Thyroid, Total/Lobe^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|9|^1000479978||TISS^Tissue^HL70487|K^Block^HL70541|||^^^88305^Soft Tissue, other than tumor,mass,lipoma,debride^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|
SPM|10|^1000479979||TISS^Tissue^HL70487|K^Block^HL70541|||^^^88305^Soft Tissue, other than tumor,mass,lipoma,debride^C4|||||||||202408080000|20240808000000||||||||||||860893^^^44D2062928&PathGroup|